Resilience Government Services, Inc.
UnclaimedPharmaceutical Preparation ManufacturingAlachua, FL
Founded
1999
Primary NAICS
325412
CAGE code
3GQS9
Federal awards
$110.3M
Overview
Resilience is a biomanufacturing CDMO improving access to complex medicines, with end-to-end solutions for safe & scalable biologics manufacturing.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Biological Product (except Diagnostic) ManufacturingResearch and Development in Biotechnology (except Nanobiotechnology)Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Defense | $0 | 4 |
| 2026 | Department of Health and Human Services | -$57,318 | 1 |
| 2025 | Department of Health and Human Services | -$38,530 | 1 |
| 2025 | Department of Defense | -$20,052,429 | 14 |
| 2024 | Department of Defense | $31,643,406 | 14 |
| 2024 | Department of Health and Human Services | $1,537,674 | 8 |
| 2023 | Department of Defense | $42,593,437 | 23 |
| 2023 | Department of Health and Human Services | $4,785,825 | 9 |
| 2022 | Department of Defense | $49,625,090 | 14 |
| 2022 | Department of Health and Human Services | $271,613 | 6 |